Table 3 Infections and non-infectious comorbidities among hospitalized adult patients in JMC wards during the study period (n = 360)
Comorbidities and risk status indicators | Wards of JMC | Total, N (%) | ||
|---|---|---|---|---|
Medical, N (%) | Surgical (%) | GYN/OBS (N) | ||
Presentence of comorbidities | ||||
No | 16 (4.4) | 81 (22.5) | 67 (18.6) | 164 (45.6) |
Yes | 136 (37.8) | 25 (6.9) | 35 (9.7) | 196 (54.4) |
Total | 152 (42.2) | 106 (29.5) | 102 (28.3) | 360 (100) |
Infections and non-infectious comorbidities* | ||||
Hypertension | 23 (11.7) | 7 (3.6) | 8 (4.1) | 38 (19.4) |
Heart failure | 29 (14.8) | 1 (0.5) | 5 (2.6) | 35 (17.9) |
Diabetes mellitus | 15 (7.7) | 2 (1.0) | 3 (1.5) | 20 (10.2) |
Acute/chronic kidney diseases | 25 (12.8) | 1 (0.5) | 0 (0.0) | 26 (13.3) |
Moderate/severe liver diseases | 10 (5.1) | 0 (0.0) | 0 (0.0) | 10 (5.1) |
Neurologic diseases | 4 (2%) | 3 (1.5) | 1 (0.5) | 8 (4.1%) |
Tuberculosis | 34 (17.3) | 3 (1.5) | 0 (0.0) | 37 (18.9) |
HIV/AIDS | 15 (7.7) | 0 (0.0) | 2 (1.0) | 17 (8.7) |
Metastatic solid tumor | 8 (4.1) | 6 (3.1) | 10 (5.1) | 24 (12.2) |
Other malignancies** | 9 (4.6) | 1 (0.5) | 4 (2.0) | 14 (7.1) |
Asthma and COPD | 16 (8.2) | 4 (2%) | 6 (3.1) | 26 (13.3) |
Neurologic diseases | 4 (2%) | 3 (1.5) | 1 (0.5) | 8 (4.1%) |
Anemia of chronic diseases | 6 (3.1) | 4 (2%) | 0 (0.0) | 10 (5.1) |
Malaria | 3 (1.5) | 0 (0.0) | 0 (0.0) | 3 (1.5) |
Esophageal candidiasis | 1 (0.5) | 1 (0.5) | 0 (0.0) | 2 (1.0) |